These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13731513)

  • 41. Effect of thyroxine on the cardiac uptake of catecholamines.
    Yoo CS; Chu YM; Lee WC
    Yonsei Med J; 1971; 12():17-20. PubMed ID: 5161476
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of inhalation anesthetics on the myocardial catecholamines and its response to norepinephrine.
    Kim WS; Robb IS; Lee WC
    Yonsei Med J; 1966; 7():39-46. PubMed ID: 5974425
    [No Abstract]   [Full Text] [Related]  

  • 43. The intra and extraneuronal uptake and release of isoproterenol by some agents: an experimental study in isolated rabbit hearts.
    Scivoletto R
    Rev Bras Pesqui Med Biol; 1974; 7(5-6):505-12. PubMed ID: 4457962
    [No Abstract]   [Full Text] [Related]  

  • 44. [Catecholamines and the heart].
    Moravec J
    Ann Med Interne (Paris); 1970 Oct; 121(10):797-806. PubMed ID: 4932839
    [No Abstract]   [Full Text] [Related]  

  • 45. [Metabolic origins of myocardial ischemia].
    PLETSCHER A
    Cardiologia (Basel); 1962; 40():97-112. PubMed ID: 14487200
    [No Abstract]   [Full Text] [Related]  

  • 46. In vivo alteration of the pathways of dopamine metabolism.
    WILLIAMS CM; BABUSCIO AA; WATSON R
    Am J Physiol; 1960 Oct; 199():722-6. PubMed ID: 13785402
    [No Abstract]   [Full Text] [Related]  

  • 47. Proceedings: A procedure to demonstrate the release of a vasoactive metabolite by catecholamines from perfused guinea-pig hearts.
    Broadley KJ
    Br J Pharmacol; 1975 Jun; 54(2):223P-224P. PubMed ID: 1148515
    [No Abstract]   [Full Text] [Related]  

  • 48. [Content of catecholamines in the kidneys, myocardium and adrenal glands in early human ontogenesis].
    Drel' KA; Gorbachev AA
    Biull Eksp Biol Med; 1972 Jun; 73(6):27-30. PubMed ID: 5050578
    [No Abstract]   [Full Text] [Related]  

  • 49. The influence of orally administered prenylamine on the storage and excreti catecholamines in humans and rats.
    Flattery KV; Shum A; Johnson GE
    Arch Int Pharmacodyn Ther; 1968 Sep; 175(1):54-62. PubMed ID: 5726461
    [No Abstract]   [Full Text] [Related]  

  • 50. Ouabain-induced myocardial catecholamine release: inhibition by propranolol.
    Ciofalo F; Treece G
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):73-9. PubMed ID: 4686110
    [No Abstract]   [Full Text] [Related]  

  • 51. [Morpho-biochemical study of catecholamine metabolism in the myocardium of dogs with fibrillation and autolysis].
    Anikin AIu; Smirnova EP; Pashentseva GA
    Biull Eksp Biol Med; 1992 Apr; 113(4):431-3. PubMed ID: 1391911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catecholamine metabolism and morphine abstinence.
    GUNNE LM
    Ann N Y Acad Sci; 1962 Jan; 96():205-10. PubMed ID: 13902965
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes of myocardial catecholamines in experimental stress and during assisted circulation].
    Holec V; Kvetnanský R
    Rozhl Chir; 1976 Mar; 55(3):160-5. PubMed ID: 935928
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of reserpine treatment, in doses "depleting" tissue catecholamines, on myocardial sensitivity to quinidine].
    Lorentz G; Gusmano R; Spanò G
    Folia Cardiol; 1967; 26(6):316-20. PubMed ID: 5631878
    [No Abstract]   [Full Text] [Related]  

  • 55. [Chronotropic action of thyroid hormones on the heart and catecholamines].
    Kandror VI; Shakhnarovich VM
    Dokl Akad Nauk SSSR; 1970 May; 192(2):455-7. PubMed ID: 5457961
    [No Abstract]   [Full Text] [Related]  

  • 56. [Oxidative phosphorylation, catecholamine content and contractile function of the myocardium in patients with acquired heart defects, operated on under artificial circulation].
    Stepanian EP; Iarlykova EI; Semenovskiĭ ML; Kuznetsova BA
    Kardiologiia; 1975 Nov; 15(11):105-11. PubMed ID: 1235122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of L-dopa on the catecholamine content and myocardial ultrastructure and contractility in heart surgery].
    Zavodskaia IS; Zabrodin ON; Zaskal'ko NI; Kucherenko RP; Nikitina NI
    Vestn Khir Im I I Grek; 1978 Feb; 120(2):13-8. PubMed ID: 644770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of reserpine treatment, in doses "depleting" tissue catecholamines, on myocardial sensitivity to procaine amide].
    Lorentz G; Lombardi D; Gusmano R
    Folia Cardiol; 1967; 26(6):321-5. PubMed ID: 5631879
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibition of catecholamine release by tolbutamide and other sulfonylureas.
    Hsu CY; Brooker G; Peach MJ; Westfall TC
    Science; 1975 Mar; 187(4181):1086-7. PubMed ID: 1114337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Heart function and the dynamics of catecholamine concentration in the adrenal tissue and the myocardium in reversible coronarogenic ishemia].
    Litvitskiĭ PF
    Kardiologiia; 1979 Oct; 19(10):105-8. PubMed ID: 502156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.